Clinical Trials Browser

Phase 2 × Advanced Melanoma × Temozolomide × Clear all

NCT07310784 2026-03-03

A Phase II Trial of LM103 in Advanced Melanoma

Phase 2 Recruiting

Advanced Melanoma